Milestone Scientific (MLSS) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Milestone Scientific Reports 30% Increase in Revenue for the Third Quarter of 2016; Reports Clinical and Commercial Progress Towards Planned Launch of Epidural Instrument
November 9, 2016 4:10 PM ESTLIVINGSTON, NJ -- (Marketwired) -- 11/09/16 -- Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results for the third quarter ending September 30, 2016.
Leonard Osser, Chief Executive Officer of Milestone Scientific stated, "I am pleased to report that we achieved a 30% increase in sales of our dental business, due in large... More
